Current Hematologic Malignancy Reports

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Current Hematologic Malignancy Reports is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1558-8211 · 1558-822X
Country
United States
Access
Not open access / not declared
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2006-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
49 days received→accepted — computed from PubMed (n=34)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

888

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

58

i10-index

503

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
96%
ORCID iDs in current deposits
23%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Curr. Hermatol. malig. rep
Source type
journal
NLM unique ID (PubMed)
101262565
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
Show all subjects (50)
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Kruppel-like factors research
  • Kruppel-like factors research
  • Cutaneous lymphoproliferative disorders research
  • Cutaneous lymphoproliferative disorders research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • T-cell and Retrovirus Studies
  • T-cell and Retrovirus Studies
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Histone Deacetylase Inhibitors Research
  • Histone Deacetylase Inhibitors Research
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Virus-based gene therapy research
  • Virus-based gene therapy research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: